New Articles  

Section "News":

Section "News":

Section "News":

Section "News":

Home Page Send a Message Switch to English Russian

Association of Clinical Trials Organizations (ACTO)
non-commercial organization of the companies/ legal entities and clinical research community engaged in clinical trials in Russia.

Home  >  Analytics & Media  >  Press Releases  >  August 01, 2013 - Prix Galien Russia 2013 Nominees for “Best Research in Russia” ...

Prix Galien Russia 2013 Nominees for “Best Research in Russia,” “Best Pharmaceutical Agent” and “Best Biotechnology Product” announced.
Winners to be Recognized by Research and Academic Leaders at October 24th Award Ceremony in Moscow.

August 01, 2013

Focus Reports, organizer of the Prix Galien Russia, today announced the 2013 nominees for the first annual Prix Galien Russia Awards. The Prix Galien Award is considered the biomedical industry’s highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines.

Nominees include research programs lead in Russia by companies and academic institutes and biomedical products that advance the human condition and which were approved by the Russian Ministry of Health during the past five years.

Nominees for the Prix Galien Russia 2013 Awards are:

Best Research in Russia (Nominees)

MM-D37K® Metamax Ltd
SkQ – mitochondrially targeted antioxidant (Visomitin ®) Mitotech LLC
OM-RCA-01® Oncomax Ltd
C12-OB® Pharma Bio LLC
Timodepressin® Pharma Bio LLC
Inhibitor of the HIV virus matrixprotein p17/MA® Quantum Pharmaceuticals LLC
Modular nanotransporters® Russian Academy of Sciences Professor Alexander S. Sobolev, Head, Laboratory of Molecular Genetics of Intracellular Transport Institute of Gene Biology

Best Pharmaceutical Agent (Nominees)

Sorafenib (Nexavar ®) Bayer HealthCare
Iloprost (Ventavis ®) Bayer HealthCare
Rivaroxaban (Xarelto ®) Bayer HealthCare
Ethinylestradiol + Drospirenone + Levomefolate Calcium (Yaz Plus ®) Bayer HealthCare
Estradiol Valerate (Qlaira ®) Bayer HealthCare
Dienogest (Visanne ®) Bayer HealthCare
Dabigatran etexilat (Pradaxa®) Boehringer Ingelheim
Telaprevir (INCIVO ®) JANSSEN pharmaceutica
Abiraterone (ZYTIGA ®) JANSSEN pharmaceutica
Pemetrexed (Alimta®) Eli Lilly
Sitagliptin+metformin (Janumet ®) MSD Pharmaceuticals
Raltegravir (Isentress ®) MSD Pharmaceuticals
Everolimus (Afinitor ®) Novartis Pharma
Vildagliptin (Galvus ®) Novartis Pharma
Fingolimod (Gilenya ®) Novartis Pharma
Nilotinib (Tasigna ®) Novartis Pharma
Agomelatine (Valdoxan ®) Les Laboratoires Servier
IVABRADINE (Coraxan ®) Les Laboratoires Servier
Roflumilast (Daxas ®) Takeda

Best Biotechnology Product (Nominees)

Adalimumab (Humira®) AbbVie
Denosumab (Xgeva®) Amgen
Abatacept (ORENCIA®) Bristol-Myers Squibb
Teriparatide (Forsteo®) Eli Lilly
Cetuximab (Erbitux®) Merck Serono, division of Merck
Epoetin alfa (Binocrit®) Sandoz
Canakinumab (Ilaris®) Novartis Pharma
ranibizumab (Lucentis®) Novartis Pharma
Tocilizumab (ACTEMRA®) F.Hoffmann-La Roche Ltd.

The Prix Galien Russia Committee comprised of nine renowned leaders in biomedical research is responsible for evaluating nominees. Winners will be honored at the Prix Galien Russia Award Ceremony in the SwissÔtel convention center, on the 24th of October 2013.

“This first Edition of the Prix Galien Russia can already be considered a success, looking at the number and variety of candidates and the quality of the Jury”, remarked Frédéric Boucheseiche, General Secretary of the Prix Galien Russia. “We are proud to honor those that drive progress in medical science and improve human condition through their innovations, research efforts and dedication.”

About Prix Galien Russia:

The Prix Galien Russia will be inaugurated in Moscow, Russia in 2013 under the auspice of an exceptional awards committee composed of eminent specialists involved in the sphere of Russian and international pharmaceutical research.

Around the world, the Prix Galien awards outstanding achievements in improving the global human condition through the development of innovative therapies.

To attend or support the Prix Galien 2013 awards ceremony or sponsor opportunities, please contact Crystelle Coury: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it


Rambler's Top100